Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.

Archives of pathology & laboratory medicine - 1 Feb 2001

Rodriguez-Pereira C, Suarez-Peñaranda J M, Barros F, Sobrido M J, Vazquez-Salvado M, Forteza J

Abstract excerpt

BACKGROUND: p53 mutations and immunoreactivity have been described in human gliomas. During the past few years, some authors have found bcl-2 overexpression in astrocytomas, although their correlation with histological grade is a matter of disagreement. A relation between bcl-2 overexpression and p53 immunoreactivity has also been suggested. OBJECTIVES: To analyze the frequency of presentation of bcl-2 and p53,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Genes, p53

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glioma

Share to Magnetic Resonance Imaging

Share to Proto-Oncogene Proteins c-bcl-2

Share to Survival Rate

Share to Tomography, X-Ray Computed

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 11175638
DOI: 10.5858/2001-125-0218-AOAFIG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.PMID 11175638Read ↗

Human gliomas with wild-type p53 express bcl-2.Semantic proximity Read ↗

The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis.Semantic proximity Read ↗

Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation.Semantic proximity Read ↗

Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival.Semantic proximity Read ↗

[Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].Semantic proximity Read ↗

TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.Semantic proximity Read ↗

Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.Semantic proximity Read ↗

Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.Semantic proximity Read ↗

Prognostic significance of co-overexpression of the EGFR/IGFBP-2/HIF-2A genes in astrocytomasSemantic proximity Read ↗

BCL-2 promotes migration and invasiveness of human glioma cells.Semantic proximity Read ↗

Prognostic impact of the expression/phosphorylation of the BH3-only proteins of the BCL-2 family in glioblastoma multiformeSemantic proximity Read ↗

Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.